Highlight
This large-scale genetic study, including 2.8 million individuals, identifies reproducible polygenic inheritance of irritable bowel syndrome (IBS), linking it to neurogastrointestinal and cardiometabolic pathways. It reveals causal relationships between IBS and triglyceride metabolism, highlighting actionable gene targets such as GCKR, and suggests potential for biomarker and drug development.
